The risks associated with pre-market and after-hours trading may be slightly higher than the regular market hours. The reason is that extended-hours trading may result in wider spreads for particular security due to lower liquidity and higher volatility as issuers often announce critical financial information outside regular trading hours. After-hours trades for Danaher Corporation (DHR) shows that investor sentiment remained broken, with the stock’s consolidated last price falling by -$2.34, or -0.94%, to $247.00. The Danaher Corporation has recorded 99,044 volume in the after hours trading session. Most recently, Yahoo Finance reported about the stock as it publicized that Danaher Partners with the University of Pennsylvania’s Center for Cellular Immunotherapies to Address Manufacturing Challenges Impacting the Uptake of Cell Therapies.
From Robots to Self-Driving Cars: 5 AI Stocks to Consider for Your Portfolio
The artificial intelligence (AI) revolution is already here and it's about to change everything we know about everything. With the global market for AI projected to grow from $137 billion in 2022 to over $1.81 trillion by 2030, there's never been a better time to invest in this burgeoning industry. That's why we've compiled a list of the Top 5 AI Stocks to Buy for 2023. These companies are at the forefront of the AI revolution, and have the potential to deliver huge returns to investors like you.
Get our free report, "Top 5 AI Stocks to Buy for 2023".
Danaher Corporation is listed on the NYSE as a member of the Healthcare sector and is a part of the Diagnostics & Research industry. At the end of the last regular session, the stock closed at $249.34 and fluctuated between $249.72 as its day high and $240.42 as its day low. The current market capitalization of Danaher Corporation is $184.60B. A total of 2.67 million shares were traded on the day, compared to an average of 2.55M shares.
Additionally, investors take into account insider trades when predicting how a stock will perform. During the recent three months, DHR has seen 12 BUY and 8 SELL insider trades, representing the acquisition of 146,230 and the disposition of 27,333 shares. Over the last 12 months, there were 36 BUYs and 33 SELLs from insiders. Insiders purchased 334,667 shares during that period but sold 1,416,375.
In the most recent transaction, Stevens Raymond C sold 8,410 shares of DHR for 264.27 per share on Jan 25. After the transaction, the Director now owns 8,394 company shares. In a previous transaction on Nov 28, Weidemanis Joakim sold 9,508 shares at 266.60 per share. DHR shares that Executive Vice President owns now total 71,498.
Among the insiders who sold shares, Couchara Georgeann disposed of 1,884 shares on Nov 15 at a per-share price of $271.61. This resulted in the SVP, Human Resources holding 2,588 shares of DHR after the transaction. In another insider transaction, McGrew Matthew sold 18,935 shares at $274.72 per share on Nov 11. Company shares held by the EVP & Chief Financial Officer now total 29,634.
It is more appealing for investors to invest in companies that pay dividends because dividends generate immediate cash flow and indicate a positive outlook for the company. Danaher Corporation pays an annual dividend of $1.08, resulting in a dividend yield of 0.43%, and it has a price to earnings (P/E) ratio of 25.80. DHR’s most recent ex-dividend date was 3/30/2023 when it declared a $0.27 quarterly dividend that was paid in cash on 4/28/2023. Previously, the company paid the dividend on 1/27/2023 with an ex-dividend date of . The DHR stock dividend was $0.25 per share in cash.
Though price targets are rarely accurate, they can exert some influence from time to time and were often accepted as valuable by the market. According to analysts who have offered 12-month price targets for DHR in the last 3 months, the mean price target is $303.55 with high estimates of $356.00 and low estimates of $270.00. In terms of 52-week highs and lows, DHR has a high of $303.82 and a low of $233.71.
As of this writing, DHR has an earnings estimate of $2.25 per share for the current quarter. EPS was calculated based on a consensus of 19 estimates, with a high estimate of $2.29 per share and a lower estimate of $2.2. The company reported an EPS of $2.56 in the last quarter, which was 13.30% higher than expectations of $2.26.
Balance Sheet Annually/Quarterly
A balance sheet is a report that shows the company’s assets and liabilities. In addition, it shows how much equity investors have invested in the company. Investors can determine the company’s prospects by calculating its financial ratios based on this information.
It may be riskier to trade before market opening and after market closing than during regular market hours. Since issuers often announce critical financial information outside regular trading hours. Extended-hours trading may result in wider spreads for particular securities due to lower liquidity and higher volatility. Currently, 27 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for DHR is Sell with a score of 4.56. A total of 16 analysts rated the stock as Buy while 3 rated it as Overweight while 7 rated it as Hold. Among the other participants, 1 thought the stock was Underweight and 0 thought it should be Sold.